Geneoscopy closes $105 M in Series C funding round to power next-generation of gastrointestinal diagnostic tests

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 million.

Early Improvement in Prurigo Nodularis With IL-31 Antagonist Maintained at 1 Year

SAN DIEGO — More than two-thirds of patients with prurigo nodularis obtained long-term relief from itching, skin lesions, and sleep disturbance with the interleukin (IL)-31

March 13, 2024

Illumina cut 12% of global staff over past year: CEO

By the numbers Q4 Revenue: $1.12 billion Up 3.6% year over year Q4 Net loss: $176 million Compared with a net loss of $140 million

February 9, 2024

Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer

CHICAGO — Early palliative care delivered via video was as effective as in-person visits on quality-of-life (QoL) measures among patients with advanced lung cancer, according

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.